379 related articles for article (PubMed ID: 28986734)
1. Antral follicle responsiveness to FSH, assessed by the follicular output rate (FORT), is altered in Hodgkin's lymphoma when compared with breast cancer candidates for fertility preservation.
Sonigo C; Comtet M; Duros S; Sifer C; Sermondade N; Grynberg M
J Assist Reprod Genet; 2018 Jan; 35(1):91-97. PubMed ID: 28986734
[TBL] [Abstract][Full Text] [Related]
2. Serum anti-Müllerian hormone levels are negatively related to Follicular Output RaTe (FORT) in normo-cycling women undergoing controlled ovarian hyperstimulation.
Genro VK; Grynberg M; Scheffer JB; Roux I; Frydman R; Fanchin R
Hum Reprod; 2011 Mar; 26(3):671-7. PubMed ID: 21177311
[TBL] [Abstract][Full Text] [Related]
3. The follicular output rate in normo-ovulating women undergoing ovarian stimulation is increased after unilateral oophorectomy.
Grynberg M; Pytel S; Peigne M; Sonigo C
Hum Reprod; 2023 Jun; 38(6):1162-1167. PubMed ID: 36961937
[TBL] [Abstract][Full Text] [Related]
4. Antral follicle responsiveness to follicle-stimulating hormone administration assessed by the Follicular Output RaTe (FORT) may predict in vitro fertilization-embryo transfer outcome.
Gallot V; Berwanger da Silva AL; Genro V; Grynberg M; Frydman N; Fanchin R
Hum Reprod; 2012 Apr; 27(4):1066-72. PubMed ID: 22279090
[TBL] [Abstract][Full Text] [Related]
5. Fertility preservation: ovarian response to freeze oocytes is not affected by different malignant diseases-an analysis of 992 stimulations.
von Wolff M; Bruckner T; Strowitzki T; Germeyer A
J Assist Reprod Genet; 2018 Sep; 35(9):1713-1719. PubMed ID: 29869766
[TBL] [Abstract][Full Text] [Related]
6. [Systematic proposal of fertility preservation by mature oocyte cryopreservation for recurrent benign ovarian tumors].
Dadoun Y; Azaïs H; Keller L; d'Orazio E; Collinet P; Decanter C
Gynecol Obstet Fertil Senol; 2017 Jun; 45(6):359-365. PubMed ID: 28506797
[TBL] [Abstract][Full Text] [Related]
7. Fertility preservation in women with malignancies: the accuracy of antral follicle count collected randomly during the menstrual cycle in predicting the number of oocytes retrieved.
Filippi F; Martinelli F; Paffoni A; Reschini M; Raspagliesi F; Somigliana E
J Assist Reprod Genet; 2019 Mar; 36(3):569-578. PubMed ID: 30478807
[TBL] [Abstract][Full Text] [Related]
8. Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients.
Grynberg M; Poulain M; le Parco S; Sifer C; Fanchin R; Frydman N
Hum Reprod; 2016 Mar; 31(3):623-9. PubMed ID: 26759139
[TBL] [Abstract][Full Text] [Related]
9. Antral follicle responsiveness assessed by follicular output RaTe(FORT) correlates with follicles diameter.
Bessow C; Donato R; de Souza T; Chapon R; Genro V; Cunha-Filho JS
J Ovarian Res; 2019 May; 12(1):48. PubMed ID: 31128593
[TBL] [Abstract][Full Text] [Related]
10. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.
Abir R; Ben-Aharon I; Garor R; Yaniv I; Ash S; Stemmer SM; Ben-Haroush A; Freud E; Kravarusic D; Sapir O; Fisch B
Hum Reprod; 2016 Apr; 31(4):750-62. PubMed ID: 26848188
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the follicular output rate after controlled ovarian stimulation with daily recombinant follicle-stimulating hormone versus corifollitropin alfa.
Griesinger G; Teal V; McCrary Sisk C; Ruman J
Eur J Obstet Gynecol Reprod Biol; 2019 Jan; 232():101-105. PubMed ID: 30529793
[TBL] [Abstract][Full Text] [Related]
12. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.
Danis RB; Pereira N; Elias RT
Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354
[TBL] [Abstract][Full Text] [Related]
13. Ovarian response to stimulation for fertility preservation in women with hematologic cancer.
Brun T; Dion L; Jaillard S; Bales D; Domin M; Lavoué V; Levêque J; Houot R; Duros S
J Gynecol Obstet Hum Reprod; 2021 May; 50(5):101925. PubMed ID: 33010467
[TBL] [Abstract][Full Text] [Related]
14. Letrozole-associated controlled ovarian hyperstimulation in breast cancer patients versus conventional controlled ovarian hyperstimulation in infertile patients: assessment of oocyte quality related biomarkers.
Goldrat O; Van Den Steen G; Gonzalez-Merino E; Dechène J; Gervy C; Delbaere A; Devreker F; De Maertelaer V; Demeestere I
Reprod Biol Endocrinol; 2019 Jan; 17(1):3. PubMed ID: 30606204
[TBL] [Abstract][Full Text] [Related]
15. What threshold values of antral follicle count and serum AMH levels should be considered for oocyte cryopreservation after in vitro maturation?
Sonigo C; Simon C; Boubaya M; Benoit A; Sifer C; Sermondade N; Grynberg M
Hum Reprod; 2016 Jul; 31(7):1493-500. PubMed ID: 27165625
[TBL] [Abstract][Full Text] [Related]
16. Ovarian reserve and response to stimulation in women undergoing fertility preservation according to malignancy type.
Lefebvre T; Mirallié S; Leperlier F; Reignier A; Barrière P; Fréour T
Reprod Biomed Online; 2018 Aug; 37(2):201-207. PubMed ID: 29784618
[TBL] [Abstract][Full Text] [Related]
17. Endometriosis reduces ovarian response in controlled ovarian hyperstimulation independent of AMH, AFC, and women's age measured by follicular output rate (FORT) and number of oocytes retrieved.
Nicolaus K; Bräuer D; Sczesny R; Jimenez-Cruz J; Bühler K; Hoppe I; Runnebaum IB
Arch Gynecol Obstet; 2019 Dec; 300(6):1759-1765. PubMed ID: 31667607
[TBL] [Abstract][Full Text] [Related]
18. Freezing oocytes or embryos after controlled ovarian hyperstimulation in cancer patients: the state of the art.
Bénard J; Duros S; El Hachem H; Sonigo C; Sifer C; Grynberg M
Future Oncol; 2016 Jul; 12(14):1731-41. PubMed ID: 27184037
[TBL] [Abstract][Full Text] [Related]
19. Prospective assessment of follicular growth and the oocyte cohort after ovarian stimulation for fertility preservation in 90 cancer patients versus 180 matched controls.
Decanter C; Robin G; Mailliez A; Sigala J; Morschhauser F; Ramdane N; Devos P; Dewailly D; Leroy-Martin B; Keller L
Reprod Biomed Online; 2018 May; 36(5):543-551. PubMed ID: 29506861
[TBL] [Abstract][Full Text] [Related]
20. Ovarian stimulation for fertility preservation in an oncology patient with etonogestrel implant in place.
Rushing JS; Appiah L; Polotsky AJ; Murray S; Foust E; Hassell K; Roeca C
J Assist Reprod Genet; 2021 Feb; 38(2):513-516. PubMed ID: 33409752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
